Answer:
The new drug will not be effective against the treatment of cancer.
Explanation:
The drug will not be effective against the cancer treatment because the drug will inhibit the dimerization of receptor tyrosine kinase (RTK) but as the Ras has undergone mutation due to replacement of one amino acid, it will be constitutively expressed and the drug is not effective in stopping the Ras functioning.
Thus, Gefitinib cannot work against the cancerous cell as it is not potent to stop the functioning of mutant Ras protein.
One half of a duplicated chromosome is called a sister chromatid
1.- Description In science, a common, vulgar, vernacular, trivial, or popular name is any name by which a species or other concept is known, and which is not the scientific name.
2.-a principal taxonomic category that ranks above class and below kingdom
3.-biology, taxonomy) A scientific name at the rank of species, with two terms: the generic name (generic epithet, the genus of the species) and the specific name (a term used only in zoology, never in botany, for the second part of a binomial) or the specific epithet (the term always used in botany, which can also be used in zoology).
